What is Precision Labs?
Precision Labs operates as a licensed reference laboratory, specializing in urinalysis services. The company employs Gold Standard LC MS/MS technology for precise drug detection and monitoring. Its services are crucial for physicians within behavioral health facilities, addiction treatment centers, OBGYN practices, and primary care settings. Precision Labs provides comprehensive testing solutions and expert consultation, aiding clinicians in interpreting results and formulating effective treatment plans. The company is committed to advancing education in addiction medicine and delivering reliable testing for medication monitoring.
How much funding has Precision Labs raised?
Precision Labs has raised a total of $367K across 2 funding rounds:
Debt
$150K
Debt
$217K
Debt (2020): $150K with participation from PPP
Debt (2021): $217K led by PPP
Key Investors in Precision Labs
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Precision Labs?
The company's recent large-scale, late-stage funding indicates a strategic push towards scaling operations and potentially expanding its technological capabilities or market reach. This capital injection is likely to fuel further development in its drug detection and monitoring services, reinforcing its position as a key partner for healthcare providers focused on patient treatment and medication adherence. Precision Labs is poised to leverage this investment to enhance its service offerings and solidify its role in advancing addiction medicine.
See full Precision Labs company page
